WNT5A and cancer: Wnt5a is ubiquitously expressed in normal tissues (Ying et al, 2008), but is often dysregulated in tumours (Wang et al, 2007, 2010) and has been controversially implicated in both tumour suppression and oncogenesis in addition to being recognised asa marker of both favourable and poor outcome in primary cancer.